CPBI

2026·06·18
SEC What Changed
CPBI, ETST, GRCE, JRSH, MDT
Grace Therapeutics (GRCE) 10-K Changes Lead 18 June 2026 Filing Roundup
Grace Therapeutics (GRCE) led the biggest 10-K filing change among 6 companies that filed annual reports on 18 June 2026, each compared against its prior-year…
Read note →: Grace Therapeutics (GRCE) 10-K Changes Lead 18 June 2026 Filing Roundup

Most Popular Research

BWSELLBabcock & Wilcox Stock Analysis (BW): Debt Maturity LoomsBabcock & Wilcox Enterprises (BW) is rated SELL as a turnaround story with strong backlog but weak earnings…POWLHOLDPowell Industries Stock Analysis (POWL): Valuation Leaves No MarginPowell Industries (POWL) carries a HOLD rating as its backlog conversion and solid cash generation are offset by…INCYHOLDIncyte Stock Analysis (INCY): JAKAFI Cliff LoomsIncyte (INCY) is rated Hold as strong cash generation and reasonable valuation are offset by the looming 2028…

Browse by Research Type

Backtesting Strategies Equity Research Quant Report SEC What Changed

Browse by Sector

AI Stocks Basic Materials Communication Services Consumer Defensive Financial Services Healthcare Industrials Real Estate Technology

Browse by Asset Class

Equity ETF

Get new reports by email.

SEC filing analysis, equity deep-dives, and backtest results — delivered when published. Free, no noise.

Subscribe Free

Double opt-in · unsubscribe anytime · no advice

lf0

Systematic research for evidence-led investors.

Research

All Research
Equity Research
Newsletter

Site

About
Contact
Subscribe

Legal

Disclaimer
Privacy Policy

lf0 publishes research and educational commentary only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell securities. Research may rely on historical data, assumptions, and backtests that may not reflect live trading results. Past performance does not guarantee future results.

CPBI

Grace Therapeutics (GRCE) 10-K Changes Lead 18 June 2026 Filing Roundup

Get new reports by email.